Avantor (AVTR) Other Non-Current Liabilities (2018 - 2026)
Avantor (AVTR) posted quarterly Other Non-Current Liabilities of $383.0 million for Q2 2026, down 2.15% year-over-year from $391.4 million in Q2 2025, and up 1.51% quarter-over-quarter from $377.3 million in Q1 2026.
Avantor (AVTR) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
Avantor's Other Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $383.0 million for Q2 2026.
- In Q2 2026, Other Non-Current Liabilities fell 2.15% year-over-year to $383.0 million; the TTM figure through Jun 2026 stood at $383.0 million (down 2.15% YoY), while the FY2025 annual figure was $378.2 million, up 5.55% from the prior year.
- Other Non-Current Liabilities for Q2 2026 stood at $383.0 million, up from $377.3 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $418.9 million in Q3 2024, with the low at $268.8 million in Q2 2023.
- The 5-year median for Other Non-Current Liabilities is $360.9 million (2022), against an average of $351.6 million.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Liabilities fell 23.55% in 2023, then surged 54.4% in 2024.
- Avantor's Other Non-Current Liabilities stood at $295.4 million in 2022, then advanced by 18.58% to $350.3 million in 2023, then rose by 2.28% to $358.3 million in 2024, then grew by 5.55% to $378.2 million in 2025, then increased by 1.27% to $383.0 million in 2026.
- Business Quant data shows AVTR's Other Non-Current Liabilities at $383.0 million in Q2 2026, $377.3 million in Q1 2026, and $378.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Avantor | 9.76 Bn | 9.45 Bn | 537.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 383.00 Mn |
| Mar 31, 2026 | 377.30 Mn |
| Dec 31, 2025 | 378.20 Mn |
| Sep 30, 2025 | 402.60 Mn |
| Jun 30, 2025 | 391.40 Mn |
| Mar 31, 2025 | 364.60 Mn |
| Dec 31, 2024 | 358.30 Mn |
| Sep 30, 2024 | 418.90 Mn |
| Jun 30, 2024 | 361.90 Mn |
| Mar 31, 2024 | 360.70 Mn |
| Dec 31, 2023 | 350.30 Mn |
| Sep 30, 2023 | 271.30 Mn |
| Jun 30, 2023 | 268.80 Mn |
| Mar 31, 2023 | 300.10 Mn |
| Dec 31, 2022 | 295.40 Mn |
| Sep 30, 2022 | 334.10 Mn |
| Jun 30, 2022 | 351.60 Mn |
| Mar 31, 2022 | 361.10 Mn |
| Dec 31, 2021 | 358.40 Mn |
| Sep 30, 2021 | 403.00 Mn |